ABIOGEN PHARMA S.P.A.

With decades of experience in development, production, and regulatory excellence, we partner with international companies to bring high-quality, proven solutions to new markets. Our portfolio covers key therapeutic areas in musculoskeletal field and beyond - and our collaborations already span over 60 countries worldwide, and we are proud to be leading in the worldwide treatment of hypovitaminosis D. Our goal is to keep on supporting and helping patients all over the world – with this in mind we are looking forward to engaging in new collaborations and committed to strengthening existing partnerships. Let’s shape the future of healthcare, together. #AbiogenPharma

Abiogen Pharma Group is heading to CPHI Milan 2026 with ABIOGEN PHARMA S.P.A. (Italy), Altamedics GmbH (Germany) and EffRx Pharmaceuticals SA (Switzerland) on the same stand. Every meaningful step, from our origins in Pisa in 1917 to the Group we are today, came out of a relationship: a licensor who trusted us with their product, a partner who took ours into their market, a company that chose our plant to manufacture theirs. Our teams, from different departments, will be on stand for all three days. Tell us what you are looking for and we will reserve the time properly:  🔹 Are you interested in distributing Abiogen Pharma Group products in your local market? Reach IBU@abiogen.it   🔹 Looking for a partner to commercialise, license or distribute your products in Italy, Germany and Switzerland through a unique European platform? Reach LicensingBD@abiogen.it   🔹 Seeking a reliable CMO/CDMO partner for technology transfer, manufacturing or supply projects? Reach CMO_CDMO@abiogen.it   🔹 Would you like to introduce your products, materials or services to Abiogen Pharma Group? Reach acquisti@abiogen.it 📅 6–8 October 2026  📍 Fiera Milano, Rho  🏢 Booth 20F25   Three days, 2,400 companies, one reason we are all in the room: nobody in this industry grows alone. 👉 Tell us what you're looking for and we'll reserve the slot: IBU@abiogen.it  

At the core of our clinical excellence, the Medical Direction acts as the silent engine driving innovation, compliance, and strategic value creation. The medical direction, thanks to clinical research team, medical affairs team and in-house biostatistics function, ensure rigorous experimental study design, post-marketing research, and real-world evidence generation. Our strong expertise in the development of osteoarticular drugs and the close collaboration with academic centers in Italy and abroad enable us to conduct innovative clinical trials, covering all phases of a clinical development. This is how we build trusted relationships with key specialists and support our international growth, step by step. #AbiogenPharma

Despite significant progress in healthcare and nutrition, hypovitaminosis D remains widespread among childre, even in developed countries. An unbalanced diet and lifestyle habits are only part of a set of risk factors contributing to this condition. Identifying and addressing modifiable risk factors is essential to ensure effective prevention. Since its founding, ABIOGEN PHARMA S.P.A. has leveraged its scientific expertise to address this issue and worked closely with physicians to improve the health of children worldwide. #AbiogenPharma #HypovitaminosisD 

In ABIOGEN PHARMA S.P.A. crediamo che la qualità dell’organizzazione passi dalla valorizzazione delle persone e dalla Parità di Genere. La nostra Politica, in linea con la prassi UNI/PdR 125:2022, riconosce la diversità come motore di innovazione e parte integrante della cultura aziendale. Scopri di più nella News dedicata alla Gender Equality Policy sul sito Corporate. https://lnkd.in/dj-PKmFb #ParitàDiGenere #GenderEquality #UNIPdR125 #DiversityAndInclusion #ValoreAllePersone #CorporateResponsibility #WorkplaceCulture

We are proud to be an Italian excellence in bone pathology therapy and a key reference in the national scientific community, thanks to our recognized leadership among specialists. We offer healthcare professionals and patients a diverse range of products for preventing and treating vitamin D deficiency and bone metabolism diseases, as well as solutions in the pain management, skin diseases, rare diseases, diabetology, cardiology and dermatology fields. With a long-standing commitment to innovation and quality, we continue to grow steadily and are excited to further expand across all our therapeutic areas. #AbiogenPharma

Un confronto scientifico che guarda al futuro, partendo da una lunga storia di ricerca, pratica clinica e collaborazione multidisciplinare. A Verona, il convegno "Ti racconto la storia…D" ha riportato al centro il tema della vitamina D, della salute delle ossa e non solo, con un approccio basato su evidenze, appropriatezza prescrittiva e personalizzazione della cura. Un'occasione importante per rileggere l'evoluzione delle conoscenze scientifiche e confrontarsi sulle prospettive future della pratica clinica. Per Abiogen Pharma, da sempre impegnata nell'area del metabolismo osseo e dell'ipovitaminosi D, iniziative come questa rappresentano un momento di dialogo fondamentale tra ricerca, clinica e cultura scientifica. Un ringraziamento a tutti gli specialisti che hanno contribuito a rendere questo appuntamento un'occasione di confronto autorevole e concreto, nel solco della scuola scientifica del professor Silvano Adami e della tradizione veronese nella ricerca sul metabolismo osseo. 🎥 Nel video, le testimonianze di Massimo Di Martino e Prisca Di Martino, Presidente e Direttore Commerciale di Abiogen Pharma, sull'importanza di sostenere il confronto scientifico e accompagnare la crescita internazionale dell'azienda, mantenendo forte il legame con la ricerca e la cultura scientifica italiane 👉 https://lnkd.in/dy64y4hi #VitaminaD #MetabolismoOsseo #RicercaScientifica #Healthcare #AbiogenPharma #InternationalGrowth

Le aziende crescono davvero quando crescono le persone. Per questo siamo orgogliosi che Abiogen Pharma sia stata inclusa nella classifica Europe's Best Employers 2026 del Financial Times e Statista, posizionandosi tra le prime 1.000 aziende europee per qualità dell'ambiente di lavoro ed esperienza professionale. La selezione si basa su un'indagine indipendente che ha raccolto oltre 6 milioni di valutazioni di lavoratori in tutta Europa, premiando le aziende maggiormente raccomandate dai propri dipendenti. Abiogen Pharma è una delle sole sei aziende italiane del settore Drugs & Biotechnology presenti nella classifica europea, confermando, dopo il riconoscimento tra i Best Employers italiani, l'eccellenza del nostro ambiente di lavoro anche a livello continentale. Un riconoscimento che valorizza il lavoro quotidiano delle nostre persone e rafforza il nostro impegno nel costruire un contesto sempre più attento a sviluppo professionale, ascolto e benessere organizzativo. #AbiogenPharma #BestEmployers #FinancialTimes #Statista #PeopleFirst 👉 https://lnkd.in/exFnQknb 👉 https://lnkd.in/dW3hfNWx

WCO‑IOF‑ESCEO 2026 | Shared science, lasting value The 2026 edition of WCO-IOF-ESCEO concluded yesterday, leaving us with a strong sense of inspiration, meaningful exchange, and collaboration. Over these days, the Abiogen Pharma Group booth became a vibrant meeting point, characterized by high‑level scientific dialogue with healthcare professionals from all over the world. The scientific excellence of the event, combined with the quality of the discussions and shared insights, made this experience particularly impactful and stimulating. We sincerely thank everyone who visited us and contributed, through interest, expertise, and open dialogue, to moments of true scientific exchange. Events like this once again highlight how shared science can become a powerful driver of growth, innovation, and commitment to patient health. International Osteoporosis Foundation

We are pleased to take part in CDMO Live Europe in Rotterdam, one of the key events for the pharmaceutical industry. At Abiogen Pharma, we offer our partners strong CDMO capabilities, integrated manufacturing expertise, and a solid commitment to quality across the entire product lifecycle. We will be attending the event, let’s connect and explore potential collaboration opportunities. For CDMO-related discussions, feel free to contact Alessandro Artioli, CDMO Manager, at alessandro.artioli@abiogen.it. https://lnkd.in/ekgNJmC2 #CDMOLive #AbiogenPharma #CDMO #PharmaManufacturing #PharmaceuticalIndustry